{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:26:06Z","timestamp":1775276766582,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Iron plays an important role in the development of perihematomal edema (PHE) in the setting of intracerebral hemorrhage (ICH). Cerebral iron is increased via direct hemoglobin release in ICH, and several studies have investigated the use of iron-chelating agents to mitigate its toxicity. However, the effect of systemic iron administration, corroborating the reverse concept, has never been investigated or reported clinically. We report the first case of systemic iron administration in the setting of hemorrhagic traumatic brain injury (TBI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 46-year-old woman was admitted to the hospital with acute moderate-to-severe TBI. Her head computed tomography (CT) scan showed bifrontal hemorrhagic contusions with mild PHE. She was started on hypertonic saline 3% continuous infusion and her condition remained stable initially. She was found to be anemic and was given intravenous iron sucrose. Shortly after iron administration, her mental status declined, and left pupil became dilated and sluggish. Repeat CT demonstrated significantly worsening PHE. This prompted maximum hyperosmolar therapy and external ventricular drain (EVD) placement which both were weaned off slowly due to liable ICPs. She was discharged home after a 25-day hospital stay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We believe this is the first report of exacerbating PHE accompanied by clinical decline after intravenous iron administration in the setting of acute hemorrhagic brain contusions. Though the effects of systemic iron administration on brain edema and the treatments targeting cerebral iron are poorly understood, the administration of systemic iron in acute TBI seems to be detrimental. More research is needed to address iron toxicity in TBI. Our case adds to the growing evidence for such a pathway in the treatment of ICH and TBI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03258-8","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T04:01:53Z","timestamp":1685419313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A case of intravenous iron administration resulting in cerebral edema expansion"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4080-6415","authenticated-orcid":false,"given":"Jonathan","family":"Espinosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umair","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Kaddouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"issue":"7","key":"3258_CR1","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1007\/s11064-007-9290-4","volume":"32","author":"JA Gaasch","year":"2007","unstructured":"Gaasch JA, Lockman PR, Geldenhuys WJ, Allen DD, Van der Schyf CJ. Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res. 2007;32(7):1196\u2013208.","journal-title":"Neurochem Res"},{"key":"3258_CR2","doi-asserted-by":"publisher","first-page":"602413","DOI":"10.3389\/fneur.2020.602413","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, Zhang H, Cheng S, Sun Y, Li H, Xiao J, et al. Association of Brain Iron Overload With Brain Edema and Brain Atrophy After Intracerebral Hemorrhage. Front Neurol. 2020;11:602413.","journal-title":"Front Neurol"},{"issue":"5","key":"3258_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S1474-4422(19)30069-9","volume":"18","author":"M Selim","year":"2019","unstructured":"Selim M, Foster LD, Moy CS, Xi G, Hill MD, Morgenstern LB, et al. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2019;18(5):428\u201338.","journal-title":"Lancet Neurol"},{"issue":"2","key":"3258_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12028-013-9861-y","volume":"19","author":"SD Yeatts","year":"2013","unstructured":"Yeatts SD, Palesch YY, Moy CS, Selim M. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocrit Care. 2013;19(2):257\u201366.","journal-title":"Neurocrit Care"},{"key":"3258_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.nicl.2017.02.007","volume":"14","author":"J Muschelli","year":"2017","unstructured":"Muschelli J, Sweeney EM, Ullman NL, Vespa P, Hanley DF, Crainiceanu CM. PItcHPERFeCT: Primary Intracranial Hemorrhage Probability Estimation using Random Forests on CT. NeuroImage Clin. 2017;14:379\u201390.","journal-title":"NeuroImage Clin"},{"issue":"4","key":"3258_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3171\/jns.2004.100.4.0672","volume":"100","author":"T Nakamura","year":"2004","unstructured":"Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, Xi G. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg. 2004;100(4):672\u20138.","journal-title":"J Neurosurg"},{"key":"3258_CR7","unstructured":"Johns Hopkins University. Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III. clinicaltrials.gov; 2019 Sep [Cited 2022 Jun 9]. Report No.: NCT01827046. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01827046"},{"issue":"70","key":"3258_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta19700","volume":"19","author":"BA Gregson","year":"2015","unstructured":"Gregson BA, Rowan EN, Francis R, McNamee P, Boyers D, Mitchell P, et al. Surgical Trial In Traumatic intraCerebral Haemorrhage (STITCH): a randomised controlled trial of Early Surgery compared with Initial Conservative Treatment. Health Technol Assess Winch Engl. 2015;19(70):1\u2013138.","journal-title":"Health Technol Assess Winch Engl"},{"issue":"17","key":"3258_CR9","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1089\/neu.2014.3644","volume":"32","author":"AD Mendelow","year":"2015","unstructured":"Mendelow AD, Gregson BA, Rowan EN, Francis R, McColl E, McNamee P, et al. Early Surgery versus Initial Conservative Treatment in Patients with Traumatic Intracerebral Hemorrhage (STITCH[Trauma]): The First Randomized Trial. J Neurotrauma. 2015;32(17):1312\u201323.","journal-title":"J Neurotrauma"},{"key":"3258_CR10","unstructured":"Penumbra Inc. MIND: A Prospective, Multicenter Study of Artemis a Minimally Invasive Neuro Evacuation Device, in the Removal of Intracerebral Hemorrhage. clinicaltrials.gov; 2022 May [cited 2022 Jun 12]. Report No.: NCT03342664. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03342664"},{"issue":"Pt B","key":"3258_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.neuropharm.2018.08.004","volume":"145","author":"RM Jha","year":"2019","unstructured":"Jha RM, Kochanek PM, Simard JM. Pathophysiology and treatment of cerebral edema in traumatic brain injury. Neuropharmacology. 2019;145(Pt B):230\u201346.","journal-title":"Neuropharmacology"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03258-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03258-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03258-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T04:04:56Z","timestamp":1685419496000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03258-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3258"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03258-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"23 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}